Bruxismo y enfermedad de Parkinson. Una revisión sistemática

  1. Fernando Santana Morín
  2. Samuel Alonso Trujillo
  3. Juan Claudio García Thompson
  4. Josmarlin González Pérez
  5. Juan Elicio Hernández Xumet
Journal:
Cuidar: Revista de Enfermería de la Universidad de La Laguna

ISSN: 2660-4426

Year of publication: 2025

Issue: 5

Pages: 73-110

Type: Article

DOI: 10.25145/J.CUIDAR.2025.05.04 DIALNET GOOGLE SCHOLAR lock_openRIULL editor

More publications in: Cuidar: Revista de Enfermería de la Universidad de La Laguna

Institutional repository: lock_openOpen access Postprint
Persistent identifier: https://hdl.handle.net/20.500.14965/6a0761a281b1221cf9e2fb27
RIULL. Repositorio Institucional de la Universidad de La Laguna: lock_openOpen access Externo

Sustainable development goals

info

SDG classification obtained using Aurora SDG artificial intelligence model.

Abstract

Evidence suggests that bruxism is a common orofacial manifestation in Parkinson’s disease (PD). This systematic review includes 10 methodologically heterogeneous studies. The findings reveal direct estimates of bruxism in PD of 46% whilst awake and 24.3% during sleep. This condition is associated with orofacial pain, dental wear, temporomandibular disorders and swallowing dysfunction. This phenomenon is contextualised within dopaminergic dysfunction and alterations in the basal ganglia. However, current evidence is predominantly based on observational designs and self-reports. There is a significant lack of objective instrumental assessments, such as polysomnography or electromyography. Bruxism constitutes a significant comorbidity in PD that requires a multidisciplinary approach. Rigorous longitudinal studies are needed to determine its true role as a clinical or prodromal marker.

Bibliographic References

  • Abderraouf Guessoum, Mohammed Abouelsoud, & Ikram Khirani. (2024). The biological basis of Parkinson’s disease: A comprehensive review. International Journal of Science and Research Archive, 12(2), 2685-2706. https://doi.org/10.30574/ijsra.2024.12.2.1473.
  • Anandan, C. & Jankovic, J. (2021). Botulinum Toxin in Movement Disorders: An Update. Toxins, 13(1), 42. https://doi.org/10.3390/toxins13010042.
  • Asociación Párkinson Tenerife (España), González Melián, N., González Pérez, J., Universidad de La Laguna (España), Revert Gironés, M.C., Universidad de La Laguna (España), Hernández Xumet, J.E., & Universidad de La Laguna (España). (2024). Influencia de la fisioterapia en las personas con enfermedad de Parkinson. Una revisión sistemática. Cuidar. Revista de Enfermería de la Universidad de La Laguna, (4), 225-259. https://doi.org/10.25145/j.cuidar.2024.04.09.
  • Baethge, C., Goldbeck-Wood, S., & Mertens, S. (2019). SANRA-a scale for the quality assessment of narrative review articles. Research Integrity and Peer Review, 4(1), 5. https://doi.org/10.1186/ s41073-019-0064-8.
  • Bakke, M., Larsen, S.L., Lautrup, C., & Karlsborg, M. (2011). Orofacial function and oral health in patients with Parkinson’s disease. European Journal of Oral Sciences, 119(1), 27-32. https://doi. org/10.1111/j.1600-0722.2010.00802.x.
  • Balestrino, R., & Schapira, A.H.V. (2020). Parkinson disease. European Journal of Neurology, 27(1), 27-42. https://doi.org/10.1111/ene.14108. 108 REVISTA CUIDAR, 5; 2025, PP. 73-110
  • Bloem, B. R., Henderson, E.J., Dorsey, E.R., Okun, M.S., Okubadejo, N., Chan, P., Andrejack, J., Darweesh, S.K.L., & Munneke, M. (2020). Integrated and patient-centred management of Parkinson’s disease: A network model for reshaping chronic neurological care. The Lancet Neurology, 19(7), 623-634. https://doi.org/10.1016/S1474-4422(20)30064-8.
  • Carra, M. C., Romandini, P., & Romandini, M. (2025). Risk of Bias Evaluation of Cross‐Sectional Studies: Adaptation of the Newcastle‐Ottawa Scale. Journal of Periodontal Research, jre.13405. https://doi.org/10.1111/jre.13405.
  • De Araújo, S.R.S., Castelo, P.M., Said, A.D.V., Fernandes, J.P.S., Neves, C.R., Diaféria, G.L.A., & Bommarito, S. (2023). Orofacial myofunctional assessment and quality of life of individuals with Parkinson’s disease. Special Care in Dentistry, 43(4), 425-434. https://doi. org/10.1111/scd.12787.
  • Dorsey, E.R., Elbaz, A., Nichols, E., Abbasi, N., Abd-Allah, F., Abdelalim, A., Adsuar, J.C., Ansha, M.G., Brayne, C., Choi, J.-Y.J., Collado-Mateo, D., Dahodwala, N., Do, H.P., Edessa, D., Endres, M., Fereshtehnejad, S.-M., Foreman, K.J., Gankpe, F.G., Gupta, R., ... Murray, C.J.L. (2018). Global, regional, and national burden of Parkinson’s disease, 19902016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology, 17(11), 939-953. https://doi.org/10.1016/S1474-4422(18)30295-3.
  • Fereshtehnejad, S.-M., Skogar, Ö., & Lökk, J. (2017). Evolution of Orofacial Symptoms and Disease Progression in Idiopathic Parkinson’s Disease: Longitudinal Data from the Jönköping Parkinson Registry. Parkinson’s Disease, 2017, 1-8. https://doi.org/10.1155/2017/7802819.
  • Kuang, B., Li, D., Lobbezoo, F., De Vries, R., Hilgevoord, A., De Vries, N., Huynh, N., Lavigne, G., & Aarab, G. (2022). Associations between sleep bruxism and other sleep-related disorders in adults: A systematic review. Sleep Medicine, 89, 31-47. https://doi.org/10.1016/j. sleep.2021.11.008.
  • Lobbezoo, F., Ahlberg, J., Raphael, K.G., Wetselaar, P., Glaros, A.G., Kato, T., Santiago, V., Winocur, E., De Laat, A., De Leeuw, R., Koyano, K., Lavigne, G.J., Svensson, P., & Manfredini, D. (2018). International consensus on the assessment of bruxism: Report of a work in progress. Journal of Oral Rehabilitation, 45(11), 837-844. https://doi.org/10.1111/joor.12663.
  • Martin, J. (2017). © Joanna Briggs Institute 2017 Critical Appraisal Checklist for Analytical Cross Sectional Studies.
  • Matusz, K., Maciejewska-Szaniec, Z., Gredes, T., Pobudek-Radzikowska, M., Glapiński, M., Górna, N., & Przystańska, A. (2022). Common therapeutic approaches in sleep and awake bruxism–An overview. Neurologia i Neurochirurgia Polska, 56(6), 455-463. https://doi. org/10.5603/PJNNS.a2022.0073.
  • Montplaisir, J. (2015). La médecine du sommeil: 1965-2015. Santé mentale au Québec, 40(2), 239255. https://doi.org/10.7202/1033054ar.
  • Pirtošek, Z. (2024). Breaking barriers in Parkinson’s care: The multidisciplinary team approach. Journal of Neural Transmission, 131(11), 1349-1361. https://doi.org/10.1007/s00702-024-02843-6.
  • Postuma, R.B., Berg, D., Stern, M., Poewe, W., Olanow, C.W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A.E., Halliday, G., Goetz, C.G., Gasser, T., Dubois, B., Chan, P., Bloem, B.R., Adler, C.H., & Deuschl, G. (2015). MDS clinical diagnostic criteria for Parkinson’s disease. Movement Disorders, 30(12), 1591-1601. https://doi.org/10.1002/mds.26424.
  • Savla, K., Vardhan, V., & Aage, D. (2021). Physiotherapy in Bruxism: A Scoping Review. International Journal of Health Sciences and Research, 11(6), 115-125. https://doi.org/10.52403/ ijhsr.20210616.
  • Shea, B.J., Reeves, B.C., Wells, G., Thuku, M., Hamel, C., Moran, J., Moher, D., Tugwell, P., Welch, V., Kristjansson, E., & Henry, D.A. (2017). AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ, j4008. https://doi.org/10.1136/bmj.j4008.
  • Tate, R.L., Mcdonald, S., Perdices, M., Togher, L., Schultz, R., & Savage, S. (2008). Rating the methodological quality of single-subject designs and n -of-1 trials: Introducing the Single-Case Experimental Design (SCED) Scale. Neuropsychological Rehabilitation, 18(4), 385-401. https://doi.org/10.1080/09602010802009201.
  • Tokumoto, K., Mino, T., Tosa, I., Omori, K., Yamamoto, M., Takaoka, K., Maekawa, K., Kuboki, T., & Kishimoto, H. (2024). Long-term follow-up of a patient with Parkinson’s disease under nursing care after replacement of fixed implant-supported prostheses with an implant overdenture: A case report. International Journal of Implant Dentistry, 10(1), 37. https://doi. org/10.1186/s40729-024-00557-8.
  • Tricco, A.C., Lillie, E., Zarin, W., O’Brien, K.K., Colquhoun, H., Levac, D., Moher, D., Peters, M.D.J., Horsley, T., Weeks, L., Hempel, S., Akl, E.A., Chang, C., McGowan, J., Stewart, L., Hartling, L., Aldcroft, A., Wilson, M.G., Garritty, C., ... Straus, S.E. (2018). PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Annals of Internal Medicine, 169(7), 467-473. https://doi.org/10.7326/M18-0850.
  • Uchima Koecklin, K.H., Aliaga-Del Castillo, A., & Li, P. (2024). The neural substrates of bruxism: Current knowledge and clinical implications. Frontiers in Neurology, 15, 1451183. https://doi.org/10.3389/fneur.2024.1451183.
  • Verhoeff, Merel Charlotte, Koutris, M., Berendse, H.W., Van Dijk, K.D., & Lobbezoo, F. (2022). Parkinson’s disease, temporomandibular disorder pain and bruxism and its clinical consequences: A protocol of a single-centre observational outpatient study. BMJ Open, 12(4), e052329. https://doi.org/10.1136/bmjopen-2021-052329.
  • Verhoeff, Merel C., Koutris, M., Tambach, S., Eikenboom, D., De Vries, R., Berendse, H. W., Van Dijk, K.D., & Lobbezoo, F. (2022). Orofacial pain and dysfunction in patients with Parkinson ‘ s disease: A scoping review. European Journal of Pain, 26(10), 2036-2059. https://doi. org/10.1002/ejp.2031.
  • Verhoeff, M.C., Koutris, M., Van Selms, M.K.A., Brandwijk, A.N., Heres, M.S., Berendse, H.W., Van Dijk, K. D., & Lobbezoo, F. (2021). Is dopaminergic medication dose associated with self-reported bruxism in Parkinson’s disease? A cross-sectional, questionnaire-based study. Clinical Oral Investigations, 25(5), 2545-2553. https://doi.org/10.1007/s00784-02003566-0.
  • Verhoeff, M.C., Lobbezoo, F., Ahlberg, J., Bender, S., Bracci, A., Colonna, A., Dal Fabbro, C., Durham, J., Glaros, A.G., Häggman‐Henrikson, B., Kato, T., Koutris, M., Lavigne, G. J., Nykänen, L., Raphael, K. G., Svensson, P., Wieckiewicz, M., & Manfredini, D. (2025). Updating the Bruxism Definitions: Report of an International Consensus Meeting. Journal of Oral Rehabilitation, 52(9), 1335-1342. https://doi.org/10.1111/joor.13985.
  • Verhoeff, M.C., Lobbezoo, F., Wetselaar, P., Aarab, G., & Koutris, M. (2018). Parkinson’s disease, temporomandibular disorders and bruxism: A pilot study. Journal of Oral Rehabilitation, 45(11), 854-863. https://doi.org/10.1111/joor.12697.
  • Verhoeff, M.C., Wetselaar, P., & Lobbezoo, F. (2024). Assessing the prevalence and risk of tooth wear in Parkinson’s disease: A narrative review. Dental and Medical Problems, 61(5), 759764. https://doi.org/10.17219/dmp/183842.
  • Weise, D., Claus, I., Dresel, C., Kalbe, E., Liepelt-Scarfone, I., Lorenzl, S., Redecker, C., & Urban, P. P. (2024). Multidisciplinary care in Parkinson’s disease. Journal of Neural Transmission, 131(10), 1217-1227. https://doi.org/10.1007/s00702-024-02807-w.
  • Zlotnik, Y., Balash, Y., Korczyn, A.D., Giladi, N., & Gurevich, T. (2015). Disorders of the Oral Cavity in Parkinson’s Disease and Parkinsonian Syndromes. Parkinson’s Disease, 2015, 1-6. https://doi.org/10.1155/2015/379482.
Data source: Dialnet